Cost is the question that decides whether most people start GLP-1 treatment at all — and it is the one with the least straightforward answer. The same medication can cost a few hundred dollars a month or well over a thousand, depending on which route you take and whether insurance participates.

Here is how the routes actually compare.

The three routes

Branded medication with insurance coverage. If your plan covers a GLP-1 for weight management, your cost is a copay — sometimes modest. The catch is that many U.S. plans exclude weight-management indications entirely, covering the same drug only for type 2 diabetes. Coverage also frequently requires prior authorisation and documentation of prior attempts.

Branded medication without coverage. List prices for branded GLP-1s run well over $1,000 per month. Manufacturer savings programmes exist and can reduce that substantially, but eligibility rules vary and some exclude people without commercial insurance.

Compounded medication through a telehealth provider. Prepared by a licensed compounding pharmacy against an individual prescription, typically bundled with the clinical review and shipping. This is where most sub-$300 pricing sits — and where the trade-off is that compounded preparations are not FDA-approved.

What drives the gap

The difference is not the underlying molecule. It is what you are buying alongside it.

A branded product’s price reflects the manufacturer’s own clinical trial programme, FDA review, manufacturing at scale and distribution. A compounded preparation skips that review — which is precisely why it is cheaper, and precisely why the trade-off is real rather than a technicality.

Tirzepatide costs more than semaglutide on every route, reflecting both its later arrival and its dual-receptor formulation.

Reading a telehealth price properly

Advertised prices in this category are frequently the first month, not the ongoing one. Before you commit, get clear answers on:

What renews, and at what price. An introductory month followed by a higher recurring charge is legitimate and common — being surprised by it is not.

What is bundled. Some prices include the clinical review, dose adjustments and shipping. Others add fees for each. A slightly higher bundled price can be cheaper in practice.

Whether longer plans actually save. Multi-month plans usually reduce the monthly rate, but not always — check the arithmetic against paying monthly rather than assuming.

Whether the dose changes the price. GLP-1 doses escalate over months. If the price rises with the dose, your month-six cost may look nothing like month one.

What happens if you stop. Cancellation terms should be stated before purchase.

What we charge

For transparency, since this article would be hollow without it:

	First month	Then
Compounded semaglutide	$89	$199/month
Compounded tirzepatide	$129	$369/month

Both include the clinical review, the medication, dose adjustments and free shipping, and the price does not change as your dose escalates. Multi-month plans are available at checkout — on tirzepatide they lower the monthly rate; on semaglutide the three- and six-month plans are $209/month, which is slightly more than paying monthly, so they suit people who prefer fewer transactions rather than a lower total.

The medical intake is free, and you are charged only if a licensed provider reviews your history and decides treatment is appropriate.

The cost nobody quotes

Two things worth budgeting for beyond the medication:

Stopping usually means regaining. In trial follow-ups, participants who discontinued GLP-1 treatment regained a substantial share of the weight lost. Whatever the monthly figure, the realistic frame is ongoing treatment, not a short course.

The rest of the protocol. The trials paired medication with diet and activity change throughout. Budgeting only for the injection is budgeting for part of the intervention.